Suven Life Sciences Limited

BSE:530239 Stock Report

Market Cap: ₹29.5b

Suven Life Sciences Management

Management criteria checks 2/4

Suven Life Sciences' CEO is Venkat Jasti, appointed in Oct 2004, has a tenure of 20.17 years. directly owns 0.001% of the company’s shares, worth ₹298.22K. The average tenure of the management team and the board of directors is 14.3 years and 10.6 years respectively.

Key information

Venkat Jasti

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure20.2yrs
CEO ownership0.001%
Management average tenure14.3yrs
Board average tenure10.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Venkat Jasti's remuneration changed compared to Suven Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-₹1b

Jun 30 2024n/an/a

-₹1b

Mar 31 2024n/an/a

-₹1b

Dec 31 2023n/an/a

-₹1b

Sep 30 2023n/an/a

-₹1b

Jun 30 2023n/an/a

-₹1b

Mar 31 2023n/an/a

-₹1b

Dec 31 2022n/an/a

-₹1b

Sep 30 2022n/an/a

-₹940m

Jun 30 2022n/an/a

-₹991m

Mar 31 2022n/an/a

-₹1b

Dec 31 2021n/an/a

-₹1b

Sep 30 2021n/an/a

-₹1b

Jun 30 2021n/an/a

-₹1b

Mar 31 2021n/an/a

-₹722m

Dec 31 2020n/an/a

-₹761m

Sep 30 2020n/an/a

-₹745m

Jun 30 2020n/an/a

-₹787m

Mar 31 2020n/an/a

-₹942m

Dec 31 2019n/an/a

₹28m

Sep 30 2019n/an/a

₹1b

Jun 30 2019n/an/a

₹871m

Mar 31 2019₹58m₹29m

-₹239m

Mar 31 2018₹47m₹25m

₹1b

Compensation vs Market: Insufficient data to establish whether Venkat's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Venkat's compensation has increased whilst the company is unprofitable.

CEO

Venkat Jasti (75 yo)

20.2yrs

Tenure

Mr. Venkateswarlu Jasti, also known as Venkat, M.Pharm. M.S., has been the Managing Director and Executive Chairman of the Board of Suven Life Sciences Limited since November 01, 2024. He is Member of Advi...

Leadership Team

NamePositionTenureCompensationOwnership
Venkateswarlu Jasti
CEO, MD & Executive Chairman20.2yrsno data0.0010%
₹ 298.2k
Sudharani Jasti
Whole-Time Director35.8yrs₹9.99m0.70%
₹ 207.0m
M. Kumar
Chief Financial Officer4.9yrsno datano data
Kundan Jha
Company Secretary & Compliance Officerless than a yearno datano data
Kalyani Jasti
President of US Operations14.3yrsno data0.00046%
₹ 135.8k

14.3yrs

Average Tenure

70yo

Average Age

Experienced Management: 530239's management team is seasoned and experienced (14.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Venkateswarlu Jasti
CEO, MD & Executive Chairman35.8yrsno data0.0010%
₹ 298.2k
Sudharani Jasti
Whole-Time Director35.8yrs₹9.99m0.70%
₹ 207.0m
Seyed Hasnain
Non-Independent & Non-Executive Director14.7yrs₹200.00kno data
Santanu Mukherjee
Independent Non-Executive Director6.6yrs₹250.00kno data
Jasthi Ananthasai Padmaja
Independent Non-Executive Director6.1yrs₹110.00kno data
Vajja Rao
Independent Directorless than a yearno datano data

10.6yrs

Average Tenure

70yo

Average Age

Experienced Board: 530239's board of directors are seasoned and experienced ( 10.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 01:27
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Suven Life Sciences Limited is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
null nullDBS Bank Ltd
null nullDolat Capital Market Pvt. Ltd.